Seminars in Respiratory and Critical Care Medicine

Papers
(The median citation count of Seminars in Respiratory and Critical Care Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension78
Improving Medication Adherence in Asthma59
Pneumonia After Solid Organ Transplantation59
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens50
Sleep, Circadian Rhythms, and Lung Cancer49
Mechanical Ventilation for COVID-19 Patients40
37
Diffuse Alveolar Hemorrhage36
Nonmalignant Pleural Effusions27
Severe Infections Due to Respiratory Viruses27
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis27
25
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease20
Prevention of Aspiration: Oral Care, Antibiotics, Others19
Lung Transplant for Chronic Obstructive Pulmonary Disease18
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function18
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative17
17
Impact of Marijuana Use on Lung Health17
Indwelling Pleural Catheter: Management of Complications17
Imaging in the Intensive Care Unit17
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection17
COVID-19-Related Pleural Diseases16
Management of Dyspnea in Patients with Neuromuscular Disorders16
Deployment-Related Respiratory Disease: Where Are We?15
Antibiotic Strategies for Severe Community-Acquired Pneumonia15
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis14
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management13
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome12
Pulmonary Physiology and Medicine of Diving12
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen12
Understanding the Updates in the Asthma Guidelines11
Definition and Epidemiology of Sepsis11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease11
Update on Sepsis Epidemiology in the Era of COVID-1911
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia11
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes11
Updates in Lung Cancer Screening: A Decade of Evidence10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease10
Survivorship Challenges and Supportive Care in Lung Cancer10
How to Survive Sepsis: Patient Testimonial10
Lung Cancer in Special Populations10
10
Bronchoscopic Lung Volume Reduction: A Review10
Lung Cancer Progress and Promise: Shaping the Future of Care10
Work-Related Sleep Disorders: Causes and Impacts10
Corticosteroid Treatment in Septic Shock9
Immunopathogenesis of Sarcoidosis9
Management of Acutely Decompensated Pulmonary Hypertension9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-199
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care9
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis9
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients8
Malignant Central Airway Obstruction: What's New?8
Interstitial Lung Disease Associated with Systemic Sclerosis8
Aspergillus and the Lung8
Intra-abdominal Infections8
Pertussis Vaccination: The Challenges Ahead8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice7
Pathological Diagnosis of Pulmonary Aspergillosis7
Arterial Blood Gases and Acid–Base Regulation7
“Long Haulers”7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy7
Life-Threatening Infections: Pulmonary and Systemic Infections7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis7
Sleep and Circadian-Related Outcomes after Critical Illness7
Glucocorticoid Treatment in Community-Acquired Pneumonia7
Aspiration Pneumonia: Preface7
7
Severe Community-Acquired Pneumonia7
Severe Community-Acquired Pneumonia in Immunocompromised Patients7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia7
Use of Antiviral Agents and other Therapies for COVID-196
HIV and COVID-19 Disease6
Control of Breathing6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure6
Pulmonary Hypertension Associated with Left Heart Disease6
Global Trends in Occupational Lung Disease5
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants5
Gas Exchange in the Lung5
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease5
The Role of Viral Infections in the Development and Progression of COPD5
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders5
Bridging Bench to the Bedside: The Imperative of Preclinical and Translational Research in Pulmonary Medicine5
The Spectrum of Pulmonary Aspergillosis5
Vaccination against Respiratory Infections in the Immunosenescent Older Adult Population: Challenges and Opportunities5
Imaging in Asthma Management5
Approach to Pulmonary Nodules in Connective Tissue Disease5
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?5
Life After COVID-19: Alterations Related to Sleep and Circadian Rhythms5
Dysregulation of Host–Pathogen Interactions in Sepsis: Host-Related Factors4
Emerging Concepts in Pathogenesis, Multiomics Applications, and Clinical Research in Lymphangioleiomyomatosis4
Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension4
Phenotyping, Precision Medicine, and Asthma4
The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis4
Pleural Diseases in Connective Tissue Diseases4
Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia4
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update4
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease4
Corrigendum: Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT4
Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology4
HAP and VAP after Guidelines4
Mediastinal Staging with Endobronchial Ultrasound in Early-Stage Non—Small Cell Lung Cancer: Is It Necessary?4
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia4
The Glucocorticoid System: A Multifaceted Regulator of Mitochondrial Function, Endothelial Homeostasis, and Intestinal Barrier Integrity4
COVID-19 Vaccines—All You Want to Know4
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care4
Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment4
Importance of and Approach to Taking a History of Exposures to Occupational Respiratory Hazards4
Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT4
Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae4
4
Malignancies Presenting with Alveolar Infiltrates: Diagnostic Pitfalls, Radiologic Clues, and Clinical Patterns4
Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy4
Aspiration after Critical Illness: Role of Endotracheal Tube, Tracheostomy, and Swallowing Disorders4
Modeling Mechanical Ventilation In Silico—Potential and Pitfalls4
Expert Review on Spontaneous Pneumothorax: Advances, Controversies, and New Directions4
Update on Drug-Induced Pneumonitis in Lung Cancer3
Advanced pulmonary sarcoidosis3
3
Early Experience on Universal Prophylaxis in Infants against Respiratory Syncytial Virus: Facts and Expectations3
3
Swallowing and Aspiration: How to Evaluate and Treat Swallowing Disorders Associated with Aspiration Pneumonia in Older Persons3
Ventilation Mechanics3
Systemic Lupus Erythematosus-related Lung Disease3
Evaluation of Neuromuscular Disease in Adults Presenting with Dyspnea3
Critical Challenges: Respiratory Infections in Immunocompromised ICU Patients3
Transmission and Risk Factors of COVID-19 among Health Care Workers3
Lysosomal Storage Disorders3
Cystic Fibrosis3
Glucocorticoid Treatment for Hospital-Acquired and Ventilator-Associated Pneumonia3
Ninth Edition of the Tumor, Node, and Metastasis Classification of Lung Cancer3
Techniques for Oxygenation and Ventilation in Coronavirus Disease 20193
Nutrition in Asthma3
Environmental Interventions for Asthma3
3
High-Resolution Computed Tomography of Cystic Lung Disease3
3
Aspiration Pneumonia3
Management of Pulmonary Arterial Hypertension2
New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness–Related Immunosuppression2
Review of Pulmonary Physiology2
Imaging of Lung Cancer Staging2
Top 7 Diagnostic Dilemmas in Cardiac Sarcoidosis: Lessons from Clinical Practice2
Glucocorticoid Therapy in COVID-192
Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine2
Advances in Multimodality Management of Localized Non-Small Cell Lung Cancer2
Nonmalignant Central Airway Obstruction: Options for Challenging Cases2
Sepsis from Science to Social Perspective2
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators2
Sepsis and Septic Shock: Evolving Evidence, Evolving Paradigms2
Heterogeneity of Lung Phagocytes and Clearance of Apoptotic Cells in Lung Injury and Repair2
Treatment of Sarcoidosis Over the Next Decade2
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia2
Pulmonary Amyloidosis2
Antimicrobial Strategies for Cystic Fibrosis2
Imaging of Lung Disease Associated with Connective Tissue Disease2
Five Questions to Help Prompt End-of-Life Planning in Neuromuscular Disease2
Genetics and Social Determinants of Health as Drivers of Epidemiologic Variation in Sarcoidosis2
Exercise and Airway Clearance Techniques in Cystic Fibrosis2
Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury2
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice2
Aspiration after Anesthesia: Chemical versus Bacterial, Differential Diagnosis, Management, and Prevention2
Medical Emergencies in Pulmonary Hypertension2
0.093829154968262